← Back to Vaccine Database

NDV-HXP-S

Viral vector (replicating) vaccine · VDDBV0552

Target & Classification

SARS-CoV-2SARS-CoV-2
Viral vector (replicating) vaccine
COVID-19
Phase 1

Clinical Development

Phase 1
Phase 2
Phase 3
Approved

Clinical Trials1

NCT IDPhaseDisease / Condition
NCT05181709 Phase 1COVID-19